Immunotech Biopharm Ltd Sustainability Reports
Immunotech Biopharm Ltd is a cellular immunotherapy biopharmaceutical company that focuses on the research, development, and commercialization of T cell immunotherapy products for treating cancers, specifically EAL, CAR-T, and TCR-T cell therapies.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
FIGI: BBG00VNXQ9N0
6 reports from 2020 to 2025
